Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment

FASEB Journal

Volumn 28, Issue 1, 2014, Pages 275-287

  Jelinic, Maria ^a   Leo, Chen Huei ^a   Post Uiterweer, Emiel D ^b,d   Sandow, Shaun L ^c   Gooi, Jonathan H ^a   Wlodek, Mary E ^a   Conrad, Kirk P ^d   Parkington, Helena ^e   Tare, Marianne ^e   Parry, Laura J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF FLORIDA   (United States)

^e MONASH UNIVERSITY   (Australia)

Author keywords

RXFP1; Vasodilation

Indexed keywords

ACETYLCHOLINE; BRADYKININ; HORMONE RECEPTOR; NITRIC OXIDE; PROSTANOID; RELAXIN INSULIN LIKE FAMILY PEPTIDE RECEPTOR 1; SERELAXIN; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; RECEPTOR; RELAXIN; RELAXIN RECEPTORS;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY; ARTICLE; BLOOD VESSEL; BLOOD VESSEL COMPLIANCE; CAVA VEIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMORAL ARTERY; FEMORAL VEIN; HUMAN; HUMAN TISSUE; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MESENTERIC ARTERY; MESENTERIC VEIN; MIDDLE AGED; NONHUMAN; ORGAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE; VASODILATATION; VEIN; ANIMAL; DRUG EFFECT; IN VITRO STUDY; METABOLISM; RXFP1; VASCULAR ENDOTHELIUM; WISTAR RAT;

RXFP1; VASODILATION;

ANIMALS; ARTERIES; BRADYKININ; ENDOTHELIUM, VASCULAR; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN; VEINS;

EID: 84894575631     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-233429     Document Type: Article

References (40)

1. Jeyabalan, A., Shroff, S. G., Novak, J., and Conrad, K. P. (2007) The vascular actions of relaxin. Adv. Exp. Med. Biol. 612, 65-87
2. Conrad, K. P. (2011) Maternal vasodilation in pregnancy: the emerging role of relaxin. Am. J. Physiol. 301, R267-R275
3. Vodstrcil, L. A., Tare, M., Novak, J., Dragomir, N., Ramirez, R. J., Wlodek, M. E., Conrad, K. P., and Parry, L. J. (2012) Relaxin mediates uterine artery compliance during pregnancy and increases uterine blood flow. FASEB J. 26, 4035-4044
4. Teerlink, J. R., Metra, M., Felker, M. G., Ponikowoski, P., Voors, A. A., Weatherley, B. D., Marmor, A., Katz, A., Grzybowski, J., Unemori, E., Teichman, S. L., and Cotter, G. (2009) Relaxin for the treatment of patients with acute heart failure (Pre-RELAXAHF): a multicentre, randomised, placebo-controlled, parallelgroup, dose-finding phase IIb study. Lancet 373, 1429-1439
5. Dschietzig, T., Teichman, S., Unemori, E., Wood, S., Boehmer, J., Richter, C., Baumann, G., and Stangl, K. (2009) Clinical trial: intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial. J. Card. Fail. 15, 182-190
6. Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Ponikowski, P., Unemori, E., Voors, A. A., Adams, K. F. J., Dorobantu, M. I., Grinfeld, L. R., Jondeau, G., Marmor, A., Masip, J., Pang, P. S., Werdan, K., Teichman, S. L., Trapani, A., Bush, C. A., Saini, R., Schumacher, C., Severin, T. M., and Metra, M. (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29-39
7. Conrad, K. P., Debrah, D. O., Novak, J., Danielson, L. A., and Shroff, S. G. (2004) Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats. Endocrinology 145, 3289-3296
8. Debrah, D. O., Conrad, K. P., Jeyabalan, A., Danielson, L. A., and Shroff, S. G. (2005) Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats. Hypertension 46, 745-750
9. Sasser, J. M., Molnar, M., and Baylis, C. (2011) Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N-omega-nitro-L-arginine methyl ester hypertensive rats. Hypertension 58, 197-204
10. St-Louis, J., and Massicotte, G. (1985) Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats. Life Sci. 37, 1351-1357
11. Bani-Sacchi, T., Bigazzi, M., Bani, D., Mannaioni, P. F., and Masini, E. (1995) Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br. J. Pharmacol. 116, 1589-1594
12. Danielson, L. A., Sherwood, O. D., and Conrad, K. P. (1999) Relaxin is a potent renal vasodilator in conscious rats. J. Clin. Invest. 103, 525-533
13. Novak, J., Ramirez, R. J., Gandley, R. E., Sherwood, O. D., and Conrad, K. P. (2002) Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. Am. J. Physiol. 283, R349-355
14. Van Drongelen, J., Ploemen, I. H. J., Pertijs, J., Gooi, J. H., Sweep, F. C. G. J., Lotgering, F. K., Spaanderman, M. E. A., and Smits, P. (2011) Ageing attenuates the vasodilator response to relaxin. Am. J. Physiol. 300, H1609-H1615
15. Van Drongelen, J., van Koppen, A., Pertijs, J., Gooi, J. H., Parry, L. J., Sweep, F. C. G. J., Lotgering, F. K., Smits, P., and Spaanderman, M. E. A. (2012) Impaired vascular responses to relaxin in diet-induced overweight female rats. J. Applied. Physiol. 112, 969-969
16. Massicotte, G., Parent, A., and St-Louis, J. (1989) Blunted responses to vasoconstrictors in mesenteric vasculature but not in portal vein of spontaneously hypertensive rats treated with relaxin. Proc. Soc. Exp. Biol. Med. 190, 254-259
17. Li, Y., Brookes, Z. L. S., and Kaufman, S. (2005) Acute and chronic effects of relaxin on vasoreactivity, myogeinc reactivity and compliance of the rat mesenteric arterial and venous vasculature. Regul. Pept. 132, 41-46
18. McGuane, J. T., Debrah, J. E., Sautina, L., Jarajapu, Y. P. R., Novak, J., Rubin, J. P., Grant, M. B., Segal, M., and Conrad, K. P. (2011) Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide. Endocrinology 152, 2786-2796
19. Fisher, C., MacLean, M., Morecroft, I., Seed, A., Johnston, F., Hillier, C., and McMurray, J. (2002) Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation 106, 292-295
20. Sandoo, A., Veldhuijzen van Zanten, J. J. C. S., Metsios, G. S., Caroll, D., and Kitas, G. D. (2010) The endothelium and its role in regulating vascular tone. Open Med. J. 4, 302-312
21. Debrah, D. O., Debrah, J. E., Haney, J. L., McGuane, J. T., Sacks, M. S., Conrad, K. P., and Shroff, S. G. (2011) Relaxin regulates vascular wall remodeling and passive mechanical properties in mice. J. Applied Physiol. 111, 260-271
22. Gooi, J. H., Richardson, M. L., Jelinic, M., Girling, J. E., Wlodek, M. E., Tare, M., and Parry, L. J. (2013) Enhanced uterine artery stiffness in aged pregnant relaxin mutant mice is reversed with exogenous relaxin treatment. Biol. Reprod 89, 18; doi: 10.1095/ biolreprod.113.108118
23. Chan, S. L., and Cipolla, M. J. (2011) Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-gamma. FASEB J. 25, 3229-3239
24. Chan, S. L., Sweet, J. G., and Cipolla, M. J. (2013) Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension. [E-pub ahead of print] FASEB J. doi: 10.1096/fj.13-230797
25. Xu, Q., Chakravorty, A., Bathgate, R. A., Dart, A. M., and Du, X. J. (2010) Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension 55, 1260-1266
26. Novak, J., Parry, L. J., Matthews, J. E., Kerchner, L. J., Indovina, K., Hanley-Yanez, K., Doty, K. D., Debrah, D. O., Shroff, S. G., and Conrad, K. P. (2006) Evidence for local relaxin ligandreceptor expression and function in arteries. FASEB J. 20, 2352-2362
27. Ferreira, V. M., Gomes, T. S., Reis, L. A., Ferreira, A. T., Razvickas, C. V., Schor, N., and Boim, M. A. (2009) Receptorinduced dilatation in the systemic and intrarenal adaptation to pregnancy in rats. PLoS One 4, e4845
28. Failli, P., Nistri, S., Quattrone, S., Mazzetti, L., Bigazzi, M., Sacchi, T. B., and Bani, D. (2002) Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells. FASEB J. 16, 252-254
29. Kubota, Y., Temelcos, C., Bathgate, R. A. D., Smith, K. J., Scott, D., Zhao, C., and Hutson, J. M. (2002) The role of insulin-3, testosterone Mullerian inhibiting substance and relaxin in rat gubernacular growth. Mol. Cell. Endocrinol. 8, 900-905
30. Kern, A., and Bryant-Greenwood, G. D. (2009) Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells. Endocrinology 150, 2419-2428
31. Tse, G. H., and Marson, L. P. (2013) A comparative study of 2 computer-assisted methods of brightfield microscopy images. [E-pub ahead of print] Appl. Immunohistochem. Mol. Morphol. 10.1097/PAI.0b013e31827ba0e1
32. Sherwood, O. D., Crnekovic, V. E., Gordon, W. L., and Rutherford, J. E. (1980) Radioimmunoassay of relaxin throughout pregnancy and during parturition in the rat. Endocrinology 107, 691-698
33. Holobotovskyy, V., Manzur, M., Tare, M., Burchell, J., Bolitho, E., Viola, H., Hool, L. C., Arnolda, L. F., McKitrick, D. J., and Ganss, R. (2013) Regulator of G protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling. Circulation 112, 781-791
34. Mazzuca, M. Q., Tare, M., Parkington, H. C., Dragomir, N. M., Parry, L. J., and Wlodek, M. E. (2012) Uteroplacental insufficiency programmes vascular dysfunction in non-pregnant rats: compensatory adaptations in pregnancy. J. Physiol. 590, 3375-3388
35. Tare, M., Parkington, H. C., and Coleman, H. A. (2000) EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries. Br. J. Pharmacol. 130, 605-618
36. Gao, Y. J., Yang, L. F., Stead, S., and Lee, R. M. (2008) Flow-induced vascular remodelling in the mesenteric artery of spontaneously hypertensive rats. Can. J. Physiol. Pharmacol. 86, 737-744
37. Conrad, K. P., and Novak, J. (2004) Emerging role of relaxin in renal and cardiovascular function. Am. J. Physiol. 287, R250-R261
38. Zieman, S. J., Melenovsky, V., and Kass, D. A. (2005) Mechanisms, pathophysiology and therapy of arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 25, 932-942
39. Dschietzig, T., Brecht, A., Bartsch, C., Baumann, G., Stangl, K., and Alexiou, K. (2012) Relaxin improves TNF-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling. Cardiovasc. Res. 95, 97-107
40. Adams, J., Schott, S., Bern, A., Renz, M., Ikenberg, K., Garbe, C., and Busch, C. (2012) A novel role for relaxin-2 in the pathogenesis of primary varicosis. PLoS ONE 7, e39021